A multimodal AI model for precision prognosis in clear cell renal cell carcinoma: A multicenter study.

The prognostic value of the MPRS was consistently validated in both the internal and external validation cohorts, with the difference in DFS remaining highly significant between the risk groups ( p < 0.001) (Fig. 2g-i ).

also in 132,142 other papers

Notably, the distribution of the MPRS showed the most distinct separation between patients with and without recurrence compared with the unimodal scores across all cohorts, demonstrating a clear trend toward higher scores indicating greater recurrence risk (Fig.

also in 19,460 other papers